MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

NeuraLace Wins Clearance for Chronic Pain Therapy

Prostock-studio -stock.adobe.com IMG_Jun172021at30915PM.jpg
NeuraLace's Axon Therapy Coil is a technology that non-invasively stimulates peripheral nerves and provides chronic nerve pain relief.

There’s a new option to help patients with chronic pain. NeuraLace Medical has received FDA clearance for its Axon Therapy, a technology that non-invasively stimulates peripheral nerves and provides chronic nerve pain relief.

The San Diego, CA-based company said its technology delivers focused magnetic pulses which activate the damaged peripheral nerve axons that are required to provide relief from chronic nerve pain. 

The Axon Therapy coil, connected to a compact stimulation module, produces strong magnetic pulses near the injured nerve during the course of the treatment. NeuraLace's low-frequency waveform leverages the principles of electromagnetic induction to create a voltage differential that elicits neuronal stimulation in the axon of the damaged nerve resulting in pain relief.

“After 10 years of R&D, we are pleased to have received FDA 510(k) clearance for Axon Therapy and we're incredibly excited to bring to market a non-opioid treatment option that provides meaningful relief for patients suffering from chronic pain,” said Shiv Shukla, Founder, and CEO of NeuraLace Medical. “We believe Axon Therapy is a significant step forward on the care continuum that is accessible to patients today and we look forward to bringing sustainable pain relief to patients by launching Axon Therapy in the U.S.”

 

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish